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’ INTRODUCTION
Metallodrug design is a burgeoning ﬁeld of bioorganometallic
chemistry with applications spanning therapeutic agents to biolo-
gical tools, probes, and diagnostics.1 Recent progress in the area has
identiﬁed transition metal-based agents where the architectural
topology, by virtue of the higher coordination numbers acces-
sible to the biologically inert transition metal, can impart out-
standing selectivity and potency toward targets such as kinases,
which are often aberrant in cancer.2 We and others recently
reported a Knoevenagel condensation of 1,3-dihydro-2H-indol-
2-one (2-oxindole) (1) with ferrocenecarboxaldehyde (2a), which
yields a mixture of (E)- and (Z)-3, which are readily separated by
chromatography. Both isomers were characterized in the solid
state and display substantial kinase inhibitory action, notably as
VEGFR-2 (vascular endothelial growth factor receptor-2)
inhibitors.3 Following this study, structuralactivity relationship
studies (SAR) have been carried out on 3 aiming to optimize the
biological activity of these molecules; hence, N-methylation,
substitution on the aryl ring by amino or bromo substituents,
hydrogenation of the exocyclic double bond, and replacement of
the ferrocene by ruthenocene have been performed, and excel-
lent kinase inhibition was observed, notably against DYRK3 and -
4 (dual-speciﬁcity tyrosine-phosphorylation-regulated kinases).4
We now report the synthesis of oxindoles substituted by metal
complexes containing bulky ligands (Scheme 1),5 in order to
study their solution and solid-state properties as well as their
biological activity since changing the metal center may have a
profound eﬀect on the biological activity of the resulting complex
especially in terms of its kinase binding (Figure 1).
Microwave-mediated (μW) condensation reactions are rou-
tine in organic synthesis, and not surprisingly a number of kinase
inhibitors have been synthesized by this methodology; however,
the use of microwaves in organometallic synthesis is much less
Figure 1. Anticipated binding mode for oxindole complexes in the
hinge region of kinases.
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ABSTRACT: 1,3-Dihydro-2H-indol-2-one (1) undergoes mi-
crowave-mediated Knoevenagel condensations with 1,2,3,4,5-
pentaphenylferrocene carboxaldehyde (2b) or (η4-tetraphenyl-
cyclobutadiene)(η5-cyclopentadienylcarboxaldehyde)cobalt
(2c) to aﬀord metallocene-substituted 3-methylidene-1,3-dihy-
dro-2H-indol-2-one 4 or 5, respectively, in excellent yields as
separable E,Z-stereoisomeric mixtures. Both 4 and 5 exhibited
poor kinase inhibition and no appreciable cytotoxicity toward a
leukemia cell line, attributed to the steric bulk of the metallocene substituents.
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commonplace.6 Microwave-mediated reactions of two sterically
demanding aldehydes, namely, 1,2,3,4,5-pentaphenyl-ferrocene
carboxaldehyde (2b)5a and (η4-tetraphenyl-cyclobutadiene)-
(η5-cyclopentadienylcarboxaldehyde)cobalt (2c)5b,c were car-
ried out with 1 given our prior success in lowering reaction times
and improving yields in the synthesis of 3 and analogues
(Scheme 1).4 The air-stable products 4 and 5 were obtained as
mixtures of geometrical isomers, which were separated by silica
gel chromatography and assigned by 1H NMR spectral compar-
ison to our previously reported (E)- and (Z)-3.3 For example, the
1H NMR spectrum of (Z)-4 showed a Cp signal, integrating as
2H, at ca. δ = 5.3 ppm, due to anisotropy of the adjacent CdO,
whereas the corresponding E-isomer displayed the similarly
attributable 2H at ca. 4.7 ppm. A similar trend was observed
for (Z)- and (E)-5 (δ = 5.7 vs 5.1 ppm, respectively).
Solid-State Studies. Air-stable crystals of (E)- and (Z)-
5, suitable for single-crystal X-ray diffraction studies, were
obtained from the diffusion of hexane into respective dichlor-
omethane solutions. Both isomers crystallize in the space group
P21/c (Figure 2, ADP = atomic displacement parameters). The
asymmetric unit of (E)-5 contains two molecules with similar
geometries. Moreover, they are also similar to the structure
of (Z)-5 and the other structures of this series (see Tables 2,
3 and Figures 2, 3).3,4 Thus, the bulky metallocene moieties in
Scheme 1. Knoevenagel Condensations of 1 with 2
Figure 2. ADP plot of (E)-5 with ellipsoids shown at the 50% probability level.
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(E)-5 and (Z)-5, compared with those of (E)-3 and (Z)-3, appear
to have little effect on the geometries of the linker and oxindole
units of the molecules. The largest difference between the molec-
ular structures of (E)-5 and (Z)-5 is the planarity of the oxindole
and metallocene units (torsion angles C10C9C2
C3 = 10.4(6) ((E)-5), 1.1(4) ((Z)-5); C110C109
C102C103 = 11.5(6) (E)-5)). To some extent this difference
is also observed between (E)-3 and (Z)-3.3 Intermolecular
H-bonded dimers of the type CdO 3 3 3HN are observed
between the oxindole units in both isomers. The crystal structure
of (Z)-5 contains solvent-accessible voids (532 Å3 per unit cell)
occupied by unidentified solvent molecules. A poor-quality
crystal structure of (Z)-4, which proves connectivity but is not
suitable for detailed analysis, was also obtained and is included in
the Supporting Information, SI.
Biological Studies.Complexes 4 and 5were evaluated against
a number of kinases, namely, DYRK14 isoforms, HIPK4
(homeodomain-interacting protein kinase 1), JAK2 (Janus ki-
nase-2), MAPKAPK3 (mitogen-activated protein kinase-
activated-3), and VEGFR2, which were previously shown to be
inhibited by 3 in the submicromolar to micromolar range.4 In all
cases 4 and 5 showed no appreciable inhibition (<10% inhibition
at 10 μM concentration), exemplified by DYRK3 and -4
(Table 1). Indeed, we next tested our complexes against PAK1
(p21-activated kinase-1), which is known to contain a large ATP
binding domain and can accommodate large octahedral metal
complexes.7 At 1030 μM compound concentration, no inhibi-
tion was observed for 4 or 5 or even for 3. Moreover, 4 and 5
showed no appreciable effects on a leukemia cell line as opposed
to 3, which had moderate micromolar cytotoxicity (Table 1).8
4 and 5 displayed no appreciable in vivo antiangiogenisis
behavior in Xenopus embryos, which is in accordance with their
in vitro screening results (Figure S2, SI).
’CONCLUSION
Bulky oxindole-bound complexes 4 and 5 have been synthesized
and tested for anticancer activity and were found to be inactive
against a range of kinase targets compared with their simpler, less
bulky ferrocene analog 3. Space-ﬁlling models emphasize the
dramatic diﬀerence in the metal complex bulk around the common
oxindole unit (Figure 4), which leads us to conclude that the bulky
environment in 4 or 5 may disfavor binding in the ATP pocket of
kinases, including that of PAK1.
’EXPERIMENTAL PROCEDURES
Details on experimental and spectroscopic methods are as outlined
previously.3 Reactions were carried out under argon using reagent grade
solvents and reagents. X-ray structures have been deposited at the CCDC
with the following codes: (E)-5, 818637; (Z)-5, 818638, and (Z)-4, 818639.
Synthesis of 4. 1,3-Dihydroindol-2-one (1) and η5-1,2,3,4,5-pen-
taphenylferrocene carboxaldehyde (2b) were combined as described
Table 1. Biological Activity of 35
compound
IC50
(μM)a
PAK1 (% residual
activity)
DYRK3 IC50
(μM)
DYRK4 IC50
(μM)
E-(3) 16 100b >10e 0.47e
Z-(3) 4.3 100b 0.39e 1.1e
E-(4) >100 88c n.d. n.d.
Z-(4) >100 93c >10 >10
E-(5) >100 100c inactived inactived
Z-(5) >100 83c inactived inactived
aMTT assay, mean of two experiments; K562 (leukemia) cell line. bAt
10 μM inhibitor concentration, % residual activity in the presence of
1 μMATP. cAt 30 μM inhibitor concentration, % residual activity in the
presence of 1 μMATP. d <10% inhibition at 10 μM. eValues taken from
ref 4.
Table 2. X-ray Crystallography Experimental Data
(E)-5 (Z)-5
empirical formula C42H30CoNO C42H30CoNO
fw 623.60 623.60
T/K 120(2) 120(2)
cryst syst monoclinic monoclinic
space group P21/c P21/c
a/Å 10.1505(2) 11.3386(2)
b/Å 27.9585(6) 26.6223(4)
c/Å 12.2065(2) 21.0764(3)
R/deg 90 90
β/deg 106.8190(10) 104.3580(10)
γ/deg 90 90
V/Å3 3315.93(11) 6163.39(17)
Dcalcd/g cm
3 1.249 1.344
indep reﬂns 7571
[Rint = 0.0813]
14 058
[Rint = 0.0720]
data/restraints/params 7571/0/406 14 058/0/811
absorp coeﬀ/mm1 0.551 0.592
R1/wR2 (observed data: F
2 > 2σ(F2)) 0.0809/0.1484 0.0668/0.1153
R1/wR2 (all data) 0.1152/0.1634 0.0946/0.1277
Figure 3. ADP plot of (Z)-5 with ellipsoids shown at the 50%
probability level.
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below for the synthesis of 5, except that toluene (0.5 mL) was used as a
cosolvent with ethanol. (E)-4 (69% yield) and (Z)-4 (30% yield) were
isolated after silica gel column chromatography using 9:1 dichloro-
methane/ethyl acetate as the elutant.
(E)-4: mp 200202 C (solid crystallized from chloroform); IR (thin
ﬁlm) νmax 1600 cm
1 (CdO stretch); 1H NMR (δ, 270.0 MHz,
CDCl3); 4.61 (2H, t, J 1.83 Hz, Fc), 4.75 (2H, t, J 1.83 Hz, Fc), 6.85
(1H, d, J 7.70 Hz, Ar), 7.31 (1H, td, J 7.70, 1.10 Hz, Ar), 6.977.14
(27H, m, ArCH), 7.20 (1H, td, J 4.77, 1.10 Hz, ArCH), 7.38 (1H, s,
CH); 13C NMR (δ, 67.0 MHz, CDCl3) 76.6, 78.6, 81.7, 88.5, 109.6,
109.9, 121.6, 122.2, 122.4, 122.9, 124.6, 126.2, 126.4, 126.9, 127.2, 127.9,
128.8, 132.2, 134.7, 137.0, 141.2, 169.5; HRMS (m/z, HNESP) for
[M þ H]þ for C49H36FeNO calcd 710.2146, obsd 710.2129.
(Z)-4: mp 180182 C; 1HNMR (δ, 270.0MHz, CDCl3) 4.62 (2H,
t, J 1.83 Hz, Fc), 5.26 (2H, t, J 1.83 Hz, Fc), 6.74 (1H, d, J 8.06 Hz, Ar),
7.31 (1H, td, J 7.70, 1.10Hz, Ar), 6.857.18 (28H, m, ArCH), 7.54 (1H,
s, CH); 13C NMR (δ, 67.0 MHz, CDCl3) 78.0, 80.7, 88.4, 109.5, 118.4,
121.4, 125.1, 125.4, 126.3, 127.1, 127.7, 132.2, 135.00, 137.2, 138.5,
169.6; HRMS (m/z, HNESP) for [M þ H]þ for C49H36FeNO calcd
710.2146, obsd 710.2128.
(E)/(Z)-4mixture: Anal. Calcd for C49H35FeNO 3 0.4 chloroform: C,
78.20, H, 4.84, N, 1.85. Found: C, 78.27, H, 4.44, N, 1.53.
General Microwave Method. Synthesis of 5. In an oven-dried
microwave tube (35 mL) equipped with a stirrer, 1,3-dihydroindol-2-
one (1) (0.013 g, 0.09 mmol) and (η4-tetraphenylcyclobutadiene)(η5-
cyclopentadienylcarboxaldehyde)cobalt (2c) (0.048 g, 0.09mmol) were
dissolved in ethanol (2.5 mL) and piperidine (0.25 μL). The reaction
mixture was allowed to stir for 2 min before being irradiated using a
microwave for 30 min at 150W and 150 C. After cooling, solvents were
removed under reduced pressure using a rotary evaporator. The crude
reaction mixture was given an aqueous workup, diluted first with ethyl
acetate (10 mL) and then washed with distilled water (10 mL) and brine
(2 10 mL, sat.). The organic layer was dried using magnesium sulfate
and filtered using fluted filter paper. The filtrate was then concentrated
in vacuo. (E)-5 (0.03 g, 54%) and (Z)-5 (0.025 g, 44%) were isolated
after silica gel column chromatography using 19:1 hexane/ethyl acetate
as the eluant.
(E)-5: mp 198200 C; 1HNMR (δ, 270.0 MHz, CDCl3) 4.94 (2H,
t, J 1.83 Hz, C5H4), 5.15 (2H, t, J 1.83 Hz, C5H4), 6.806.92 (2H, m,
Ar), 7.00 (1H, s, dCH), 7.127.24 (13H, m, Ar), 7.377.40 (8H, m,
Ar), 7.517.64 (2H, m, Ar); 13C NMR (δ, 67.0 MHz, CDCl3) 80.5,
82.9, 105.2, 107.9, 117.1, 117.7, 117.9, 118.6, 119.4, 120.2, 121.3, 122.2,
123.7, 124.3, 129.7, 130.6, 134.2, 165.8; HRMS (m/z, HNESP) for
C42H31CoNO [M þ H]þ calcd 624.1738, obsd 624.1724.
(Z)-5: mp 214216 C; 1HNMR (δ, 270.0MHz, CDCl3) 4.91 (2H,
t, J 1.83 Hz, C5H4), 5.71 (2H, t, J 1.83 Hz, C5H4), 6.61 (1H, s, dCH),
6.77 (1H, d, J 6.48 Hz, Ar), 6.906.96 (2H, m, Ar), 7.087.20 (14H, m,
Ar), 7.367.40 (8H, m, Ar); 13C NMR (δ, 67.0 MHz, CDCl3) 86.9,
87.8, 90.5, 109.0, 118.4, 121.3, 122.9,125.6, 126.5, 127.4, 128.1, 128.7,
133.2, 135.4, 138.5, 167.8; HRMS (m/z, HNESP) for C42H31CoNO
[M þ H]þ calcd 624.1738, obsd 624.1725.
(E)/(Z)-5mixture: Anal. Calcd for C42H30CoNO: C, 80.89, H, 4.85,
N, 2.25. Found: C, 80.96, H, 4.93, N, 2.32.
X-ray Crystallography. Single-crystal X-ray diffraction analyses
of (E)-5 and (Z)-5 were performed using a Bruker APEXII CCD
diffractometer mounted at the window of a Bruker FR591 rotating
anode (MoKR = 0.71073 Å) and equipped with anOxford Cryosystems
cryostream device (SI, Table S1). Data were processed using the Collect
package,9 and unit cell parameters were refined against all data. An
empirical absorption correction was carried out using SADABS.10 The
structures were solved by either direct methods using SHELXS-9711 or
charge-flipping using SUPERFLIP12 and refined on Fo
2 by full-matrix
least-squares refinements using SHELXL-97.13 All non-hydrogen atoms
were refined with anisotropic displacement parameters. All hydrogen
atoms were added at calculated positions and refined using a riding
model with isotropic displacement parameters based on the equivalent
isotropic displacement parameter (Ueq) of the parent atom. Figures were
produced using OLEX214 and MERCURY.15 The (Z)-5 structure con-
tains two solvent-accessible voids per unit cell (216 Å3 each), which were
investigated using PLATON SQUEEZE.16
Figure 4. Molecular structures of (Z)-3, (Z)-4, and (Z)-5. The units common to all structures are shown in ball-and-stick representation, while the
diﬀerences in the metallocene substituents are shown in space-ﬁlling representation (see SI).
Table 3. Selected Bond Lengths (Å), Angles (deg), and
Torsion Angles (deg) for (E)-5 and (Z)-5
(E)-5 (Z)-5
C9C10 1.454(4) 1.454(6)
C9C2 1.349(4) 1.356(6)
C1C2 1.495(4) 1.492(6)
C2C3 1.471(4) 1.459(6)
C1N1 1.363(4) 1.361(5)
N1C8 1.399(4) 1.397(6)
O1C1 1.234(4) 1.226(5)
C109C110 1.449(4)
C109C102 1.345(4)
C101C102 1.502(4)
C102C103 1.470(4)
C101N101 1.363(4)
N101C108 1.399(4)
O101C101 1.235(4)
C2C9C10 131.8(3) 133.4(4)
C1N1C8 110.9(2) 111.5(4)
O1C1N1 125.4(3) 124.3(4)
C102C109C110 130.8(3)
C101N101C108 110.9(3)
O101C101N101 125.8(3)
C10C9C2C3 10.4(6) 1.1(4)
C110C109C102C103 11.5(6)
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